1. Home
  2. PTLE vs ICCM Comparison

PTLE vs ICCM Comparison

Compare PTLE & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PTLE

PTL LTD Ordinary Shares

HOLD

Current Price

$5.67

Market Cap

51.3M

Sector

Energy

ML Signal

HOLD

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.62

Market Cap

41.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTLE
ICCM
Founded
2013
2006
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
51.3M
41.4M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
PTLE
ICCM
Price
$5.67
$0.62
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
722.0K
283.7K
Earning Date
05-15-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$53.39
Revenue Next Year
N/A
$174.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$0.54
52 Week High
$16.17
$1.40

Technical Indicators

Market Signals
Indicator
PTLE
ICCM
Relative Strength Index (RSI) 50.89 45.40
Support Level $0.14 $0.58
Resistance Level $16.17 $0.74
Average True Range (ATR) 1.80 0.06
MACD -0.43 -0.01
Stochastic Oscillator 14.50 13.39

Price Performance

Historical Comparison
PTLE
ICCM

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: